Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-02-11 @ 1:07 AM
Study NCT ID:
NCT06594393
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-28
First Post:
2024-08-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
Sponsor:
Xinnate AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TCP25-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None